CXCR4 heterogeneous expression in esophageal squamous cell cancer and stronger metastatic potential with CXCR4-positive cancer cells

Diseases of the Esophagus

Volumn 27, Issue 3, 2014, Pages 294-302

  Lu, C L ^a   Guo, J ^a   Gu, J ^a   Ge, D ^a   Hou, Y Y ^a   Lin, Z W ^a   Ding, J Y ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

CXCR4; Esophageal squamous cell cancer; Heterogeneous expression; Metastasis; Migration

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CXCR4 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER PROGNOSIS; CANCER RECURRENCE; CELL MIGRATION; CELL PROLIFERATION; CELL SUBPOPULATION; COLONY FORMATION; ESOPHAGEAL SQUAMOUS CELL CANCER; ESOPHAGUS CANCER; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; CELL MOTION; CHEMISTRY; DISEASE FREE SURVIVAL; ESOPHAGUS TUMOR; GENE EXPRESSION; GENETICS; LYMPH NODE; MIDDLE AGED; PATHOLOGY; SECONDARY; SURVIVAL RATE; TUMOR CELL LINE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RECEPTORS, CXCR4; SURVIVAL RATE;

EID: 84898599016     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/dote.12100     Document Type: Article

References (20)

1. Song P I, Liang H, Fan J H, Wei W Q, Wang G Q, Qiao Y L. Long-term survival after esophagectomy for early esophageal squamous cell carcinoma in Linxian, China. J Surg Oncol 2011; 104: 176-180.
2. Wang L S, Chow K C, Chi K H etal. Prognosis of esophageal squamous cell carcinoma: analysis of clinicopathological and biological factors. Am J Gastroenterol 1999; 94: 1933-1940.
3. Xu Q R, Zhuge X P, Zhang H L, Ping Y M, Chen L Q. The N-classification for esophageal cancer staging: should it be based on number, distance, or extent of the lymph node metastasis? World J Surg 2011; 35: 1303-1310.
4. Greenstein A J, Litle V R, Swanson S J, Divino C M, Packer S, Wisnivesky J P. Prognostic significance of the number of lymph node metastases in esophageal cancer. J Am Coll Surg 2008; 206: 239-246.
5. Kryczek I, Wei S, Keller E, Liu R, Zou W. Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis. Am J Physiol Cell Physiol 2007; 292 (3): C987-995.
6. Burger J A, Kipps T J. CXCR4. a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 2006; 107: 1761-1767.
7. Tachibana K, Hirota S, Iizasa H etal. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 1998; 393 (6685): 591-594.
8. Furusato B, Mohamed A, Uhlen M, Rhim J S. CXCR4 and cancer. Pathol Int 2010; 60: 497-505.
9. Lu C L, Ji Y, Ge D, Guo J, Ding J Y. The expression of CXCR4 and its relationship with matrix metalloproteinase-9/vascular endothelial growth factor in esophageal squamous cell cancer. Dis Esophagus 2011; 24: 283-290.
10. Gockel I, Schimanski C C, Heinrich C etal. Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma. BMC Cancer 2006; 6: 290.
11. Kaifi J T, Yekebas E F, Schurr P etal. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer. J Natl Cancer Inst 2005; 97: 1840-1847.
12. Clarke M F, Dick J E, Dirks P B etal. Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006; 66: 9339-9344.
13. Kato M, Kitayama J, Kazama S, Nagawa H. Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma. Breast Cancer Res 2003; 5 (5): R144-150.
14. Nian W Q, Chen F L, Ao X J, Chen Z T. CXCR4 positive cells from Lewis lung carcinoma cell line have cancer metastatic stem cell characteristics. Mol Cell Biochem 2011; 355 (1-2): 241-248.
15. Hermann P C, Huber S L, Herrler T etal. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell 2007; 1: 313-323.
16. Gros S J, Graeff H, Drenckhan A etal. CXCR4/SDF-1α-mediated chemotaxis in an in vivo model of metastatic esophageal carcinoma. In Vivo 2012; 26: 711-718.
17. Huang Y C, Hsiao Y C, Chen Y J, Wei Y Y, Lai T H, Tang C H. Stromal cell-derived factor-1 enhances motility and integrin up-regulation through CXCR4, ERK and NF-kappaB-dependent pathway in human lung cancer cells. Biochem Pharmacol 2007; 74: 1702-1712.
18. Liang Z, Brooks J, Willard M etal. CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway. Biochem Biophys Res Commun 2007; 359: 716-722.
19. Samara G J, Lawrence D M, Chiarelli C J etal. CXCR4-mediated adhesion and MMP-9 secretion in head and neck squamous cell carcinoma. Cancer Lett 2004; 214: 231-241.
20. Hartmann T N, Burger J A, Glodek A, Fujii N, Burger M. CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells. Oncogene 2005; 24: 4462-4471.